Vimarsana
Biggest News Aggregation in the World

Page 4 - Initial Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Initial Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Initial Phase Today - Breaking & Trending Today

Update on the production test and request for extension of the Initial Phase of Block 70, onshore Oman - Vimarsana News

Update on the production test and request for extension of the Initial Phase of Block 70, onshore Oman

Maha Energy AB (publ) (“Maha” or the “Company”) announces the results of the initial short-term production test on Block 70 in the Sultanate of Oman (“Initial Phase”). All 8 (eight) production wells drilled in the 2022/2023 drilling program were tested for short term and 5 (five) produced oil to surface at an initial estimated average rate of 300 barrels of oil per day per well, while 3 (three) had to be suspended after producing water and gas but before producing any oil. Even though more than

Source: yahoo.com
VBI Vaccines Reports First Quarter 2023 Financial Results - Vimarsana News

VBI Vaccines Reports First Quarter 2023 Financial Results

PreHevbrio global net revenue increased 90% quarter-over-quarter from Q4 2022 to Q1 2023 as access to PreHevbrio continues to broaden – now available at several U.S. retail pharmacy chains... | May 15, 2023

Watch the moment show-off motorcyclist taunts police by pulling wheelies in front of patrol car - Vimarsana News

Watch the moment show-off motorcyclist taunts police by pulling wheelies in front of patrol car

The frustrated police officers appear to make no effort to stop the biker's dangerous antics in Leeds as he repeatedly gets into the kneeling position on the saddle and vanishes into the traffic.

Seagen to Present New Clinical and Preclinical Data From Broad Portfolio of Targeted Cancer Therapeu - Vimarsana News

Seagen to Present New Clinical and Preclinical Data From Broad Portfolio of Targeted Cancer Therapeu

- Interim results from Phase 2 innovaTV 207 trial of tisotumab vedotin in head and neck cancer to be presented -- Initial Phase 1 dose-escalation data for SEA-TGT monotherapy in advanced malignancies to be disclosed -- Preclinical data and discovery research underscore Seagen’s mission to innovate through next-gener...

G1 Therapeutics Provides Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights - Vimarsana News

G1 Therapeutics Provides Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights

01.03.2023 - - Achieved $31.3 Million in Net Revenue from Sales of COSELA (trilaciclib) for Full Year 2022, Representing 182% Growth Over 2021; Provided 2023 Net COSELA Revenue Guidance of $50 to $60 Million - - Announced Top Line Results from Pivotal Phase 3 ...